Mesothelioma Legal News
asbestos exposure, mesothelioma, Mesothelioma News

WHO Reclassifies Firefighting as High-Risk Occupation for Cancer

 

The World Health Organization has reclassified firefighting to its highest level of occupational risk for cancer after extensive research confirmed an alarming level of malignant mesothelioma incidence. The International Agency for Research on Cancer, which is part of WHO, found that firefighters had a 58% higher risk than the general population of developing mesothelioma, a […]

The post WHO Reclassifies Firefighting as High-Risk Occupation for Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Immunotherapy, mesothelioma, Mesothelioma News, Treatment

UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma

 

Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option after its recent approval by the National Health Service for first-line treatment. The long-awaited approval comes almost two years after the U.S. Food and Drug Administration granted a similar approval of Opdivo […]

The post UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Study: Those Exposed to Asbestos Should Not Take Beta-Carotene

 

Taking beta-carotene health supplements could increase the risk of lung cancer or death from cardiovascular disease for anyone who is regularly exposed to asbestos, according to a panel of medicine experts. Based on existing scientific evidence, the U.S. Preventive Services Task Force concluded recently that the potential harms of beta-carotene supplements outweigh any benefits, particularly […]

The post Study: Those Exposed to Asbestos Should Not Take Beta-Carotene appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Awareness/Advocacy, mesothelioma, Mesothelioma News, Peritoneal, Pleural, Treatment

MARF to Host International Symposium on Malignant Mesothelioma

 

Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending. The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on […]

The post MARF to Host International Symposium on Malignant Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, mesothelioma, Mesothelioma News

New Study Underscores Importance of Worldwide Asbestos Ban

 

The push for a worldwide ban on asbestos gained momentum recently with the latest study linking national consumption levels of the toxic mineral with corresponding levels of asbestos-related diseases. An ecological association between asbestos and asbestos-related diseases was made in 70 countries, doubling the number found in a similar study released in 2007. Environmental Health […]

The post New Study Underscores Importance of Worldwide Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News, Pleural

Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma

 

Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with no cure. The recent focus on identifying genetic mutations that make individuals more susceptible to certain cancers – including mesothelioma – has led to related research on how best to combat […]

The post Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News

Drug Repurposing Study Could Identify New Mesothelioma Treatments

 

The next breakthrough in the treatment of malignant mesothelioma may be quietly underway. An international research team based at Temple University in Philadelphia recently identified four drug compounds – already being used safely for noncancerous conditions – that have shown impressive potential for treating mesothelioma. They were part of a novel drug repurposing project aimed […]

The post Drug Repurposing Study Could Identify New Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Mesothelioma News

EPA Finalizes Asbestos Risk Evaluation Goals with Part 2 Assessment

 

Utilizing recent public feedback, the U.S. Environmental Protection Agency finalized its strategy and goals for the much-anticipated Risk Evaluation for Asbestos Part 2. Its final scope document, released June 29, clarified the EPA’s intentions, which will build on the previously released and much-maligned Part 1. A broader Part 2 will be published late in 2024. […]

The post EPA Finalizes Asbestos Risk Evaluation Goals with Part 2 Assessment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial

 

Princess Margaret Cancer Centre in Toronto recently opened a first-of-its-kind clinical trial that hopes to build on earlier pioneering efforts to turn pleural mesothelioma into a more manageable, potentially survivable disease. Expectations are high. This single-center phase II clinical trial is named SMARTEST, and follows in the wake of earlier mesothelioma trials SMART and SMARTER […]

The post Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Mesothelioma Clinical Trials Test Targeted Gene Therapy

 

For some patients, the future of mesothelioma cancer treatment may hinge on a pair of phase I clinical trials that opened earlier this year to study promising new drugs targeting specific genetic mutations. Precision medicine may finally be taking hold with malignant mesothelioma, clearing the path for significant, long-overdue advancements. The one-size-fits-all approach is fading. […]

The post Mesothelioma Clinical Trials Test Targeted Gene Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), Mesothelioma News

Asbestos Abatement Laws Being Enforced

 

Cities and counties throughout the country are paying the price for failing to adhere to the tightening safety protocols that cover the handling and disposal of toxic asbestos in existing structures. Dothan, Alabama, became the latest city to pay for its negligence, agreeing to a $3,000 settlement with the state’s Department of Environmental Management, stemming […]

The post Asbestos Abatement Laws Being Enforced appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Novel Clinical Trial Helping Late-Stage Mesothelioma Patients

 

Late-stage patients with pleural mesothelioma have survived longer than anticipated — with good quality of life — in a phase I clinical trial studying the effectiveness of a novel combination treatment. The treatment involves galinpepimut-S, the latest targeted cancer vaccine also known as GPS, in combination with Opdivo, a popular immunotherapy drug. Memorial Sloan Kettering […]

The post Novel Clinical Trial Helping Late-Stage Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), Mesothelioma News

Sudden Rise in Asbestos Imports as Ban Draws Closer

 

Importation of raw chrysotile asbestos into the United States increased dramatically earlier this year, despite the growing movement toward tighter regulation and a potential future ban of the product. The chloralkali industry — the only known user of raw asbestos today within the U.S. — imported an estimated 114 metric tons over the first three […]

The post Sudden Rise in Asbestos Imports as Ban Draws Closer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Carbone: Building the Guide to BAP1 Mutation in Mesothelioma

 

Over the years, I have “collected” many families affected by the BAP1 cancer syndrome, a novel medical condition we discovered in 2011. Pathogenic germline mutations, most of them BAP1 mutations, are estimated to be found in 10% of all those diagnosed with mesothelioma. BAP1 germline mutations occur in people born with only one functioning copy […]

The post Carbone: Building the Guide to BAP1 Mutation in Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Targeted Therapy Making Progress with Pleural Mesothelioma

 

Future treatment of pleural mesothelioma cancer continued its move toward a more personalized, targeted approach with the latest results from a multi-center clinical trial involving tazemetostat, a novel protein inhibitor. Tazemetostat, also known as the brand name Tazverik, showed impressive effectiveness in a second line setting for patients with the BAP1 genetic mutation. The disease […]

The post Targeted Therapy Making Progress with Pleural Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.